Procyon Advisors, LLC Astrazeneca PLC Transaction History
Procyon Advisors, LLC
- $1.61 Billion
- Q1 2025
A detailed history of Procyon Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Procyon Advisors, LLC holds 37,854 shares of AZN stock, worth $2.53 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
37,854
Previous 33,695
12.34%
Holding current value
$2.53 Million
Previous $2.21 Million
26.05%
% of portfolio
0.17%
Previous 0.14%
Shares
21 transactions
Others Institutions Holding AZN
# of Institutions
1,380Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.04 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.74 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.51 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.61 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.3 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $207B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...